4 February 2020 | Revisiting criteria for psychosis in Alzheimer’s disease and related dementias- towards better phenotypic classification and biomarker research | Fischer, CE; Ismail, Z; Youakim, JM; et al. |
11 February 2020 | The mental and physical health of older adults with a genetic predisposition for autism | Creese, B; Corbett, A; Ballard, C; et al. |
8 January 2020 | Psychosis-associated DNA methylomic variation in Alzheimer’s disease cortex | Pishva, SE; Creese, B; Smith, A; et al. |
16 September 2020 | Drug repositioning and repurposing for Alzheimer disease | Ballard, C; Aarsland, D; Cummings, J; et al. |
30 July 2020 | Dementia prevention, intervention, and care: 2020 report of the Lancet Commission | Livingston, G; Huntley, J; Sommerlad, A; et al. |
31 October 2020 | Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer’s disease and Lewy body dementias | Low, CYB; Lee, JH; Lim, FTW; et al. |
5 December 2020 | Online education and cognitive behavior therapy improve dementia caregivers' mental health: a randomized trial | Fossey, J; Charlesworth, G; Fowler, J-A; et al. |
11 November 2020 | Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease | Daunt, P; Ballard, CG; Creese, B; et al. |
24 November 2020 | Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study | Richardson, K; Loke, YK; Fox, C; et al. |
13 October 2020 | Psychosis in Alzheimer's Disease | Ballard, C; Kales, HC; Lyketsos, C; et al. |